Device, drug makers ask US FDA to clarify off-label policy
This article was originally published in SRA
Executive Summary
Seven major medtech and pharmaceutical manufacturers have filed a joint citizen petition with the US Food and Drug Administration asking the agency to clarify its regulations and policies on how companies can disseminate information on off-label uses of marketed medical devices and drugs1.